Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3077% below fair value
$3.04−0.12 (-3.80%)
Close on Nov 18, 2026Market cap $57.14MP/E –Yield –
Outset Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Outset Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$38.88M. For fiscal 2025 it was -$47.13M. The highest annual figure on record is -$47.13M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$47.13M | – |
| FY2024 | Dec 31, 2024 | -$117.22M | – |
| FY2023 | Dec 31, 2023 | -$134.81M | – |
| FY2022 | Dec 31, 2022 | -$154.05M | – |
| FY2021 | Dec 31, 2021 | -$133.37M | – |
| FY2020 | Dec 31, 2020 | -$108.09M | – |
| FY2019 | Dec 31, 2019 | -$73.59M | – |
| FY2018 | Dec 31, 2018 | -$48.21M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.75M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.74M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.48M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.79M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$33.46M | – |
| Q1 FY2024 | Mar 31, 2024 | -$46.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$25.50M | – |
| Q3 FY2023 | Sep 30, 2023 | -$34.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$28.97M | – |
| Q1 FY2023 | Mar 31, 2023 | -$45.57M | – |
| Q4 FY2022 | Dec 31, 2022 | -$36.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$37.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$40.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$39.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.53M | – |
| Q3 FY2021 | Sep 30, 2021 | -$28.62M | – |
| Q2 FY2021 | Jun 30, 2021 | -$31.69M | – |
| Q1 FY2021 | Mar 31, 2021 | -$39.54M | – |
| Q4 FY2020 | Dec 31, 2020 | -$28.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$30.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$21.35M | – |
| Q1 FY2020 | Mar 31, 2020 | -$27.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.72M | – |
See a number that looks wrong?